QPS Holdings Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
1,250
- Latest Deal Type
-
2ndary - Private
- Financing Rounds
-
10
- Investments
-
7
QPS Holdings General Information
Description
Provider of contract research services intended to support pharmaceutical and biotechnology drug development. The company offers bioanalytical assays, preclinical toxicology studies, clinical trials, laboratory services, neuropharmacology models and translational medicine programs, enabling pharmaceutical and biotechnology clients to accelerate drug discovery and clinical development through custom-built research programs.
Contact Information
Website
www.qps.comCorporate Office
- Delaware Technology Park
- 3 Innovation Way, Suite 240
- Newark, DE 19711
- United States
Corporate Office
- Delaware Technology Park
- 3 Innovation Way, Suite 240
- Newark, DE 19711
- United States
QPS Holdings Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
QPS Holdings Comparisons
Industry
Financing
Details
QPS Holdings Competitors (39)
One of QPS Holdings’s 39 competitors is CTI Clinical Trial and Consulting, a Private Equity-Backed company based in Covington, KY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| CTI Clinical Trial and Consulting | Private Equity-Backed | Covington, KY | ||||
| TFS International | Private Equity-Backed | Lund, Sweden | ||||
| Medkey | Private Equity-Backed | Shanghai, China | ||||
| Aragen Life Sciences | Private Equity-Backed | Hyderabad, India | ||||
| Exagen | Formerly VC-backed | Vista, CA |
QPS Holdings Patents
QPS Holdings Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2009100216-A1 | Composition for sustained release delivery of proteins or peptides | Inactive | 08-Feb-2008 | ||
| WO-2009100222-A1 | Non-polymeric compositions for controlled drug delivery | Inactive | 08-Feb-2008 | ||
| CA-2657911-A1 | Pharmaceutical compositions for sustained release delivery of peptides | Active | 11-Jul-2006 | ||
| WO-2008008363-A1 | Pharmaceutical compositions for sustained release delivery of peptides | Inactive | 11-Jul-2006 | ||
| CA-2637569-A1 | Pharmaceutical compositions with enhanced stability | Active | 18-Jan-2006 | A61K47/34 |
QPS Holdings Signals
QPS Holdings Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
QPS Holdings Investments & Acquisitions (7)
QPS Holdings’s most recent deal was a Buyout/LBO with Miami Research Associates. The deal was made on 01-Dec-2012.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Miami Research Associates | 01-Dec-2012 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Scantox Neuro | 29-Aug-2012 | Buyout/LBO | Other Pharmaceuticals and Biotechnology | ||
| QPS-Qualitix Taiwan | 08-Mar-2011 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| Center of Toxicology & Preclinical Sciences | 14-Feb-2011 | Buyout/LBO | Laboratory Services (Healthcare) | ||
| QPS-Bioserve India | 25-Jan-2011 | Buyout/LBO | Laboratory Services (Healthcare) |
QPS Holdings Exits (1)
QPS Holdings’s most recent exit was on 29-Aug-2012 from Scantox Neuro. The exit was categorized as with 3 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Scantox Neuro | 29-Aug-2012 | Completed |
|
QPS Holdings Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Miami Research Associates | South Miami, FL | 1996 |
QPS Holdings FAQs
-
When was QPS Holdings founded?
QPS Holdings was founded in 1995.
-
Where is QPS Holdings headquartered?
QPS Holdings is headquartered in Newark, DE.
-
What is the size of QPS Holdings?
QPS Holdings has 1,250 total employees.
-
What industry is QPS Holdings in?
QPS Holdings’s primary industry is Other Healthcare Services.
-
Is QPS Holdings a private or public company?
QPS Holdings is a Private company.
-
What is QPS Holdings’s current revenue?
The current revenue for QPS Holdings is .
-
Who are QPS Holdings’s investors?
Argentum (New York), First Analysis, and Graycliff Partners have invested in QPS Holdings.
-
Who are QPS Holdings’s competitors?
CTI Clinical Trial and Consulting, TFS International, Medkey, Aragen Life Sciences, and Exagen are some of the 39 competitors of QPS Holdings.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process